Tenaya Therapeutics Given New 18.00 Price Target at Chardan Capital

TNYA Stock  USD 3.47  0.11  3.07%   
About 72% of Tenaya Therapeutics' investor base is looking to short. The analysis of the overall investor sentiment regarding Tenaya Therapeutics suggests that many traders are alarmed. The current market sentiment, together with Tenaya Therapeutics' historical and current headlines, can help investors time the market. In addition, many technical investors use Tenaya Therapeutics stock news signals to limit their universe of possible portfolio assets.
  
Tenaya Therapeutics had its price objective reduced by Chardan Capital from 20.00 to 18.00 in a report published on Thursday,Benzinga reports. They currently have a buy rating on the stock. TNYA has been the subject of a number of other research reports. Leerink Partners reissued an outperform rating on shares of

Read at thelincolnianonline.com
news
  

Tenaya Therapeutics Investor Sentiment by Other News Outlets

Investor sentiment, mood or attitude towards Tenaya Therapeutics can have a significant impact on its stock price or the market as a whole. This sentiment can be positive or negative, and various factors, such as economic indicators, news events, or market trends, can influence it. When investor sentiment is positive, investors are more likely to buy stocks, increasing demand and increasing the stock price. Positive investor sentiment can be driven by good news about the company or the broader market, such as solid earnings reports or positive economic data.
Note that negative investor sentiment can cause investors to sell stocks, leading to a decrease in demand and a drop in the stock price. Negative sentiment can be driven by factors such as poor earnings reports, negative news about the company or industry, or broader economic concerns. It's important to note that investor sentiment is just one of many factors that can affect stock prices. Other factors, such as company performance, industry trends, and global economic conditions, can also play a significant role in determining the value of a stock.

Tenaya Therapeutics Fundamental Analysis

We analyze Tenaya Therapeutics' financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Tenaya Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Tenaya Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Cash Flow From Operations

Cash Flow From Operations Comparative Analysis

Tenaya Therapeutics is currently under evaluation in cash flow from operations category among its peers. Operating Cash Flow reveals the quality of a company's reported earnings and is calculated by deducting company's income taxes from earnings before interest, taxes, and depreciation (EBITDA). In other words, Operating Cash Flow refers to the amount of cash a firm generates from the sales or products or from rendering services. Operating Cash Flow typically excludes costs associated with long-term investments or investment in marketable securities and is usually used by investors or analysts to check on the quality of a company's earnings.

Tenaya Therapeutics Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with Tenaya Therapeutics stock to make a market-neutral strategy. Peer analysis of Tenaya Therapeutics could also be used in its relative valuation, which is a method of valuing Tenaya Therapeutics by comparing valuation metrics with similar companies.

Peers

Tenaya Therapeutics Related Equities

ALXOAlx Oncology   12.16   
0%
100.0%
DRTSAlpha Tau   7.86   
0%
64.0%
IGMSIGM Biosciences   7.47   
0%
61.0%
GOSSGossamer Bio   4.29   
0%
35.0%
VINCVincerx Pharma   3.57   
0%
29.0%
INZYInozyme Pharma   2.95   
0%
24.0%
BMEABiomea Fusion   0.41   
0%
3.0%
AKROAkero Therapeutics   0.28   
2.0%
0%
STOKStoke Therapeutics   0.33   
2.0%
0%
RANIRani Therapeutics   0.99   
8.0%
0%
OCULOcular Therapeutix   1.21   
9.0%
0%
GLUEMonte Rosa   1.35   
11.0%
0%
BCYCBicycle Therapeutics   1.91   
15.0%
0%
CRVSCorvus Pharmaceuticals   9.24   
75.0%
0%

Complementary Tools for Tenaya Stock analysis

When running Tenaya Therapeutics' price analysis, check to measure Tenaya Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Tenaya Therapeutics is operating at the current time. Most of Tenaya Therapeutics' value examination focuses on studying past and present price action to predict the probability of Tenaya Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Tenaya Therapeutics' price. Additionally, you may evaluate how the addition of Tenaya Therapeutics to your portfolios can decrease your overall portfolio volatility.
FinTech Suite
Use AI to screen and filter profitable investment opportunities
Sync Your Broker
Sync your existing holdings, watchlists, positions or portfolios from thousands of online brokerage services, banks, investment account aggregators and robo-advisors.
Bonds Directory
Find actively traded corporate debentures issued by US companies
Technical Analysis
Check basic technical indicators and analysis based on most latest market data